137 related articles for article (PubMed ID: 32437041)
21. Inhibiting IL-6 in COVID-19: we are not sure.
Honore PM; Barreto Gutierrez L; Kugener L; Redant S; Attou R; Gallerani A; De Bels D
Crit Care; 2020 Jul; 24(1):463. PubMed ID: 32718345
[No Abstract] [Full Text] [Related]
22. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients With Near-Normal Respiratory Compliance.
Huang CF; Sun PT; Tay CK
Crit Care Med; 2020 Oct; 48(10):e993-e994. PubMed ID: 32541570
[No Abstract] [Full Text] [Related]
23. Treatment of COVID-19 by Inhaled NO to Reduce Shunt?
Hedenstierna G; Chen L; Hedenstierna M; Scaramuzzo G
Am J Respir Crit Care Med; 2020 Aug; 202(4):618. PubMed ID: 32579020
[No Abstract] [Full Text] [Related]
24. Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?
Tibiriçá E; De Lorenzo A
Obesity (Silver Spring); 2020 Aug; 28(8):1374. PubMed ID: 32403201
[No Abstract] [Full Text] [Related]
25. Dealing With the CARDS of COVID-19.
Marini JJ
Crit Care Med; 2020 Aug; 48(8):1239-1241. PubMed ID: 32697499
[No Abstract] [Full Text] [Related]
26. Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
Koumbourlis AC; Motoyama EK
Am J Respir Crit Care Med; 2020 Aug; 202(4):624-626. PubMed ID: 32579022
[No Abstract] [Full Text] [Related]
27. Rapid Deterioration of Hospital-Acquired COVID-19 in a Patient on Extracorporeal Left Ventricular Assist Support.
Oliveros E; Mahmood K; Yammine M; Chau V; Fox A; Ahmed S; Anyanwu A; Pinney S; Mancini D; Lala A; Barghash M
Heart Lung; 2020; 49(6):808-811. PubMed ID: 33010519
[TBL] [Abstract][Full Text] [Related]
28. Early application of prone position for management of Covid-19 patients.
Golestani-Eraghi M; Mahmoodpoor A
J Clin Anesth; 2020 Nov; 66():109917. PubMed ID: 32473503
[No Abstract] [Full Text] [Related]
29. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients.
Calò LA; Bertoldi G; Davis PA
Pharmacol Res; 2020 Aug; 158():104903. PubMed ID: 32430287
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19.
Sobol I; Yuzefpolskaya M; Roth Z; Colombo PC; Horn E; Takeda K; Sayer G; Uriel N; Naka Y
J Card Fail; 2020 Oct; 26(10):895-897. PubMed ID: 32956813
[No Abstract] [Full Text] [Related]
31. Severe Covid-19 disease: rather AVDS than ARDS?
Mahjoub Y; Rodenstein DO; Jounieaux V
Crit Care; 2020 Jun; 24(1):327. PubMed ID: 32527297
[No Abstract] [Full Text] [Related]
32. Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report.
Wang C; Kang K; Gao Y; Ye M; Lan X; Li X; Zhao M; Yu K
Ann Intern Med; 2020 Sep; 173(6):499-501. PubMed ID: 32422085
[No Abstract] [Full Text] [Related]
33. Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective.
Korada SKC; Mann JA; Hasan AK; Baliga RR; Mokadam NA; Benza RL; Vallakati A
Heart Lung; 2020; 49(6):688-691. PubMed ID: 32861886
[TBL] [Abstract][Full Text] [Related]
34. A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.
Nicolson PL; Welsh JD; Chauhan A; Thomas MR; Kahn ML; Watson SP
Platelets; 2020 Jul; 31(5):685-690. PubMed ID: 32552307
[No Abstract] [Full Text] [Related]
35. COVID-19 Lung Injury and "Typical" Acute Respiratory Distress Syndrome: The Danger of Presumed Equivalency.
Kyle-Sidell C
Ann Am Thorac Soc; 2020 Sep; 17(9):1171-1172. PubMed ID: 32432895
[No Abstract] [Full Text] [Related]
36. Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?
Jose RJ; Manuel A
Obesity (Silver Spring); 2020 Jun; 28(6):1007. PubMed ID: 32294322
[No Abstract] [Full Text] [Related]
37. Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19.
Combet M; Pavot A; Savale L; Humbert M; Monnet X
Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32631838
[TBL] [Abstract][Full Text] [Related]
38. Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.
Imamura T; Nikhil N
J Card Surg; 2020 Oct; 35(10):2872-2873. PubMed ID: 33043665
[No Abstract] [Full Text] [Related]
39. Risk of peripheral arterial thrombosis in COVID-19.
Mestres G; Puigmacià R; Blanco C; Yugueros X; Esturrica M; Riambau V
J Vasc Surg; 2020 Aug; 72(2):756-757. PubMed ID: 32417015
[No Abstract] [Full Text] [Related]
40. Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.
Di Nardo M; Dalle Ore A; Starr J; Cecchetti C; Amodeo A; Testa G
Perfusion; 2020 Sep; 35(6):562-564. PubMed ID: 32580648
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
